Earnings summaries and quarterly performance for HealthLynked.
Research analysts covering HealthLynked.
Recent press releases and 8-K filings for HLYK.
HealthLynked Corp. Issues Senior Secured Convertible Promissory Note to CEO-Controlled Trust
HLYK
Debt Issuance
Convertible Preferred Issuance
- HealthLynked Corp. issued a Senior Secured Convertible Promissory Note with an Original Principal Amount of $5,715,811.98 on February 2, 2026, to the Mary S. Dent Gifting Trust, which is controlled by the company's Chief Executive Officer and Chairman, Dr. Michael Dent.
- This note was issued in exchange for the cancellation and termination of prior obligations, including existing promissory notes totaling $4,338,191.70 in principal and $737,180.26 in accrued interest, $339,840.02 in undocumented advances, and $300,600.00 in unpaid compensation liability due to Dr. Dent.
- The note carries an annual interest rate of 12%, matures on February 2, 2029, and is convertible into shares of common stock at the holder's option at a conversion price of $4.25 per share.
- The company's obligations under this note are secured by a first priority lien on all of its assets.
1 day ago
HealthLynked Announces Strategic Partnership with PBACO
HLYK
New Projects/Investments
- HealthLynked Corp. announced a strategic consulting partnership with PBACO Holding, LLC on December 23, 2025.
- PBACO is a physician-led value-based care organization that operates across 26 states, supports over 15,000 physicians, and manages over 400,000 patient lives across various ACO programs.
- The partnership aims to strengthen HealthLynked's ability to integrate with large insurance payers and deploy its AI-driven care-coordination solutions across broad insured populations.
- PBACO will provide strategic advisory and operational support to HealthLynked for value-based contracting strategy, payer alignment, and payer relationship development.
Dec 23, 2025, 2:00 PM
Ask Fintool AI Agent
Get instant answers from SEC filings, earnings calls & more